Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/11146

Title:	Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient.
Authors:	Romero-Laorden, N Piñeiro-Yañez, E Gutierrez-Pecharroman, A Pacheco, M I Calvo, E Al-Shahrour, F Castro, E Olmos, D
metadata.dc.subject.mesh:	Aged BRCA2 Protein Benzimidazoles Genes, BRCA2 Germ-Line Mutation Humans Loss of Heterozygosity Male Poly(ADP-ribose) Polymerase Inhibitors Prostatic Neoplasms, Castration-Resistant
Issue Date:	2017
URI:	http://hdl.handle.net/10668/11146
metadata.dc.identifier.doi:	10.1093/annonc/mdx067
Appears in Collections:	Producción 2020

Files in This Item:

There are no files associated with this item.

This item is protected by original copyright

Show full item record Recommend this item

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.

RISalud